Int J Oral Maxillofac Implants. 2019 May/June;34(3):681–691. doi: 10.11607/jomi.6940. Epub 2018 Dec 5.
Scientific publications have recently found that bone graft quality and implant survival rates were not influenced by antrostomy membrane coverage during maxillary sinus floor augmentation with a lateral approach. The aim of this study was to evaluate the stability of the bone substitute after a maxillary sinus floor augmentation procedure with or without using a covering membrane.
This retrospective study evaluated all patients who were enrolled between April 2016 and January 2017. The stability of the bone graft inside the sinus cavity as well at the level of the lateral bone window was assessed through preoperative and postoperative cone beam computed tomography images up to 6-month follow-up. The clinical postoperative morbidity was evaluated following a visual analog scale (VAS) protocol.
Maxillary sinus floor augmentation with a lateral approach was performed in 41 patients. In 17 cases (10 women/7 men, mean age: 55.4 years), a barrier membrane was used to cover the lateral bone window (control group), and in 24 cases (13 women/11 men, mean age: 56.2 years), no membrane was used (test group). The bone graft dislodgement within the buccal mucosa at 6 months postoperative ranged from 0 to 12.2 mm (mean value: 3.8 ± 3.1 [standard deviation] mm) in the test group and from 0 to 2.3 mm (mean value: 0.5 ± 0.4 mm) in the control group. The postoperative pain and swelling complications were significantly more important for the test group (3.3 ± 1.4/4.3 ± 4.5, respectively) than for the control group (2.1 ± 0.9/2.7 ± 0.9).
On the basis of this preliminary study, it appears that the use of a barrier membrane to cover the lateral bone window during maxillary sinus floor augmentation surgery with a lateral approach reduces the postoperative dislodgement of the bone graft throughout the sinus antrostomy and prevents the bone substitute particles penetrating within the buccal mucosa, which is related to postoperative morbidity.
最近的科学出版物发现,在经外侧入路行上颌窦底提升术中,使用或不使用覆盖膜对窦膜的覆盖并不会影响骨移植物质量和种植体存活率。本研究旨在评估在不使用覆盖膜的情况下,上颌窦底提升术后骨替代物的稳定性。
这是一项回顾性研究,评估了 2016 年 4 月至 2017 年 1 月期间所有入组的患者。通过术前和术后的锥形束 CT 图像,在 6 个月的随访期间评估窦腔内和外侧骨窗水平的骨移植物稳定性。采用视觉模拟量表(VAS)方案评估术后临床并发症的发生率。
41 例患者行经外侧入路上颌窦底提升术。其中 17 例(10 女/7 男,平均年龄:55.4 岁)使用屏障膜覆盖外侧骨窗(对照组),24 例(13 女/11 男,平均年龄:56.2 岁)未使用膜(试验组)。术后 6 个月,试验组颊侧黏膜内的骨移植物移位范围为 0 至 12.2mm(平均值:3.8 ± 3.1mm),对照组为 0 至 2.3mm(平均值:0.5 ± 0.4mm)。试验组术后疼痛和肿胀并发症明显比对照组更严重(分别为 3.3 ± 1.4/4.3 ± 4.5)。
基于这项初步研究,在经外侧入路行上颌窦底提升术中使用屏障膜覆盖外侧骨窗可以减少窦口处骨移植物的术后移位,并防止骨替代物颗粒穿透颊侧黏膜,这与术后并发症有关。